Syntegra Private Wealth Group LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Syntegra Private Wealth Group LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,689 shares of the healthcare conglomerate’s stock after buying an additional 173 shares during the quarter. Syntegra Private Wealth Group LLC’s holdings in UnitedHealth Group were worth $1,416,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Robbins Farley bought a new stake in shares of UnitedHealth Group in the third quarter worth about $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in UnitedHealth Group in the first quarter worth about $35,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Truist Financial restated a “buy” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Thursday, November 30th. Stephens reiterated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. HSBC restated a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Barclays started coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price for the company. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Price Performance

NYSE UNH traded up $1.60 during trading hours on Thursday, hitting $494.70. 3,805,551 shares of the company’s stock traded hands, compared to its average volume of 4,097,774. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market capitalization of $456.08 billion, a PE ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The firm’s 50-day moving average is $503.10 and its 200-day moving average is $518.61. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. UnitedHealth Group’s revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the business posted $5.34 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.